Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement-immunoglobulin interactions

V D Miletic1, M M Frank

  • 1Duke University Medical Center, Department of Pediatrics, Durham, North Carolina 27710, USA.

Current Opinion in Immunology
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement activation.

Immunology today·2014
Same author

Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent.

Gene therapy·2008
Same author

Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies.

Molecular therapy : the journal of the American Society of Gene Therapy·2004
Same author

Complement activation influences Staphylococcus aureus adherence to endothelial cells.

Infection and immunity·2003
Same author

Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.

Infection and immunity·2003
Same author

Complement 1 inhibitor is a regulator of the alternative complement pathway.

The Journal of experimental medicine·2001
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Immunoglobulin

Area of Science:

  • Immunology
  • Molecular Biology
  • Autoimmune Disease Research

Background:

  • Circulating immunoglobulins (Ig) regulate complement binding, influencing autoimmune disease manifestations.
  • Understanding immunoglobulin's role in complement activation is crucial for autoimmune disease research.

Purpose of the Study:

  • To elucidate the molecular mechanisms of immunoglobulin's interaction with the complement system.
  • To identify key structural motifs and modifications in immunoglobulins critical for complement activation pathways.

Main Methods:

  • Molecular analysis of immunoglobulin G (IgG) and immunoglobulin M (IgM) mutants.
  • Investigation of glycosylation's role in complement C1q binding and alternative pathway initiation.

Main Results:

Related Experiment Videos

  • A core Glu-X-Lys-X-Lys motif in IgG is essential for C1q binding.
  • Specific proline residues in IgG and IgM are critical for classical complement pathway initiation.
  • Glycosylation of IgG and IgA heavy chains impacts C1q binding and alternative pathway initiation, respectively.
  • Complement component C3 may play a significant role in both antigen presentation and intracellular antigen processing.

Conclusions:

  • Specific molecular structures and glycosylation patterns of immunoglobulins dictate their interaction with the complement system.
  • These interactions are critical for controlling autoimmune disease and may involve C3 in antigen processing.